Stroke biobank aims to unlock genetic secrets of brain attacks

NCT ID NCT03291392

Recruiting now Knowledge-focused Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is building a biobank of blood, spinal fluid, and tissue samples from 500 Chinese adults, including stroke patients, their families, and healthy volunteers. Researchers will analyze the samples to find genetic markers linked to stroke and its complications. The goal is to advance understanding of stroke biology and pave the way for better prevention and treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this biobank could help identify genetic risk factors for stroke, leading to better prevention and treatment strategies in the future.
What could go wrong: This is an observational biobank study, not a treatment trial. It may take years before any findings translate into real-world medical advances.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATHEROSCLEROSIS, CEREBRAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atherosclerosis cerebral atherosclerosis hereditary disease intracranial arteriosclerosis ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATHEROSCLEROSIS, CEREBRAL GENETIC DISEASE STROKE, ISCHEMIC

Contacts and locations

Locations

Chinese University of Hong Kong
RECRUITING

Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.